COMMUNIQUÉS West-GlobeNewswire

Efficacité de la combinaison NBTXR3 (premier produit de sa classe), radiothérapie et immunothérapie avec anti-PD-1 démontrée dans le cancer du Poumon résistant dans des modèles précliniques in vivo
02/04/2019
Efficacité de la combinaison NBTXR3 (premier produit de sa classe), radiothérapie et immunothérapie avec anti-PD-1 démontrée dans le cancer du Poumon résistant dans des modèles précliniques in vivo Données présentées au [...]
Molina Healthcare Announces First Quarter 2019 Earnings Release and Conference Call Dates
02/04/2019
LONG BEACH, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the first quarter ended March 31, 2019. Molina Healthcare will issue [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
02/04/2019
Company Announcement Copenhagen, Denmark; April 2, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 146,961 shares as a consequence of the exercise of employee warrants. The increase is [...]
SuperSonic Imagine to Highlight Breast Ultrasound Imaging with Aixplorer® MACH 30 at SBI/ACR Breast Imaging Symposium
02/04/2019
Hollywood, Florida, April 4-7, 2019 Visit Supersonic Imagine at Booth # 208 AIX-EN-PROVENCE, France, April 02, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specialising in medical [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2019
02/04/2019
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2019 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica : Nombre total de droits de vote et d'actions composant le capital social au 31 mars 2019
02/04/2019
Nombre total de droits de vote et d’actions composant le capital social au 31 mars 2019 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton- [...]
Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2019
02/04/2019
LYON, France, April 02, 2019 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social - 31 Mars 2019
02/04/2019
LYON, France, 02 avr. 2019 (GLOBE NEWSWIRE) -- Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : [...]
OSE Immunotherapeutics Presents New Clinical and Preclinical Data on its Immuno-Oncology Portfolio at AACR 2019
02/04/2019
Oral presentation highlights investigator case reports showing early signs of activity of Tedopi® in patients with non-small cell lung cancer in third-line treatment after checkpoint inhibitor failure Poster [...]
« L’autisme doit devenir une priorité nationale »
02/04/2019
MONTRÉAL, 02 avr. 2019 (GLOBE NEWSWIRE) -- Le taux de prévalence de l’autisme devrait en faire une priorité nationale. En 2018, le taux de prévalence de l’autisme au Canada était de 1 sur 66 et celui du Québec de 1 sur [...]
Chr. Hansen and Lonza establish a 50/50 joint venture to pioneer the emerging market for live biotherapeutic products
02/04/2019
Company Announcement No. 4/2019 Announcement attached below For further information, please contact: Head of Investor Relations Martin Riise Tel.: +45 5339 2250 Investor Relations Officer Annika Stern Tel.: +45 2399 [...]
Amfora Licenses Gene Editing Technology
02/04/2019
SAN FRANCISCO, April 02, 2019 (GLOBE NEWSWIRE) -- Today Amfora, a biotechnology company, announced it has reached a non-exclusive research and commercial license agreement with Corteva Agriscience™, the Agriculture [...]
Dr. Ellen Turner Expands Wellness Testing Opportunities in Dallas
02/04/2019
Starting in 2019, the Texas-based physician began offering tests for hormone imbalances, heavy metals, and more DALLAS, April 02, 2019 (GLOBE NEWSWIRE) -- As a Dallas-based dermatologist , Dr. Ellen Turner has long [...]
University at Buffalo Selected as First U.S. Site for LaparoGuard Augmented Surgical System
02/04/2019
Buffalo, NY, April 02, 2019 (GLOBE NEWSWIRE) -- Surgeons are pioneering LaparoGuard, a suite of new technologies for patients, at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB). [...]
Massive Bio to Present SYNERGY-AI Trial-in-Progress Poster Presentation at Upcoming AACR 2019 using its AI Clinical Trial Matching Technology, and Announces Strategic Partnership in Precision Oncology with US-Based Admera Health
02/04/2019
NEW YORK, April 02, 2019 (GLOBE NEWSWIRE) -- Massive Bio, Inc., a leader in providing simplified and affordable access to clinical trials and precision oncology to cancer patients treated at community-based oncology [...]
Zynerba Pharmaceuticals to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
02/04/2019
DEVON, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Wildflower Brands and HelloMD to Expand Business Together
02/04/2019
VANCOUVER, British Columbia, April 02, 2019 (GLOBE NEWSWIRE) -- via NetworkWire: Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “Company”) is pleased to have entered into a delivery fulfillment agreement with [...]
Visual Snow Initiative to present a Váró-abstract brain sculpture to MIT Neuroscientist Ed Boyden for his support to advance a ‘Visual Snow Syndrome’ cure
02/04/2019
Attn.: Boston Assignment/Photo Editors, Art Editors, Healthcare Editors, Tech Editors Media Advisory: April 3 - Photo & Interview Opportunity Who: Dr. Ed Boyden , Assoc. Professor, Biological Engineering and Brain [...]
Aptevo Therapeutics Presents New Preclinical Data for APVO436 and ALG.APV-527 at the American Association for Cancer Research 2019 Annual Meeting
02/04/2019
APVO436 Preclinical Data Continue to Show Promising Results Supporting Clinical Development for the Treatment of Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS) and Differentiation from a [...]

Pages